Cell line · CVCL_0566

U266B1

Cancer cell line, Homo sapiens. Plasma cell myeloma. 93 papers.

4 sourcescell-lines-2026-11-14-0.1.0

Cite this record

ConductScience Library. U266B1. Cell lines, record CVCL_0566. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_0566

On this page

Cell line

As Cellosaurus gives it.

Name: U266B1
Accession: CVCL_0566
RRID: RRID:CVCL_0566
Synonyms: U266-B1, U266 B1, U-266, U 266, U266, U266S, U266BL, U266 Bl, 266 Bl
Species: Homo sapiens (Human)
Sex: Male
Age at sampling: 53Y
Category: Cancer cell line
Diseases: Plasma cell myeloma (NCIt C3242); Multiple myeloma (ORDO Orphanet_29073)
Derived from: Peripheral blood (in situ)
Cell type: Plasma cell
Entry created: 2012-04-04
Entry updated: 2025-08-14

Source Cellosaurus

Problems0

Cellosaurus records no problem for this cell line.

None in this release.

Papers93

Paper	Journal	Year	How we know	Source
Unc-51 like kinase 3 (ULK3) contributes to autophagy and cell survival in multiple myeloma.	Nat Commun	2026	Its Methods give the RRID and name the line	PubMed
CD47 promotes myeloma cell growth through JAK-STAT3/MYC signalling and is targetable by ruxolitinib.	Br J Haematol	2026	Its Methods give the RRID and name the line	PubMed
Inhibition of Fibroblast Growth Factor Receptor 3 Signaling by Ponatinib Reduces Growth and Cytokine Production of Multiple Myeloma Cells.	Int J Mol Sci	2026	Its Methods give the RRID and name the line	PubMed
Targeting BCMA in multiple myeloma with a trifunctional NK cell engager.	Cell Rep Med	2026	Its Methods give the RRID and name the line	PubMed
Syndecan-1-targeted therapeutic antibody impairs macropinocytosis and elicits antitumor immunity in pancreatic cancer.	Cell Rep Med	2026	Its Methods give the RRID and name the line	PubMed
Anti-myeloma activity of the CXCR4 antagonist WZ811.	J Mol Med (Berl)	2026	Its Methods give the RRID and name the line	PubMed
Targeting PRKCN, an Essential Driver Orchestrating mTOR-IRF4 Axis Independently of Kinase Activity, in Multiple Myeloma.	Adv Sci (Weinh)	2026	Its Methods give the RRID and name the line	PubMed
CD70-Targeting CAR NK Cells Overcome BCMA Downregulation and Improve Survival in High-risk Multiple Myeloma Models.	Blood Cancer Discov	2026	Its Methods give the RRID and name the line	PubMed
Therapeutic potential of PRMT1 as a critical survival dependency target in multiple myeloma.	BMC Cancer	2025	Its Methods give the RRID and name the line	PubMed
Targeting scavenger receptor class B type 1 with a bioinspired ligand induces apoptosis or ferroptosis in AML.	Blood Neoplasia	2025	Its Methods give the RRID and name the line	PubMed

1 to 10 of 93

See all 93 papers

Relatives14

Relation	Cell line	Accession	Source
Derived from it	AF10 [Human myeloma]	CVCL_C833	Cell lines
Derived from it	FU-266	CVCL_J235	Cell lines
Derived from it	SKO-007	CVCL_4974	Cell lines
Derived from it	U-266/70	CVCL_0015	Cell lines
Derived from it	U-266/84	CVCL_0016	Cell lines
Derived from it	U266-PSR	CVCL_E5J9	Cell lines
Derived from it	U266/ADM	CVCL_GZ72	Cell lines
Derived from it	U266/BR	CVCL_VJ36	Cell lines
Derived from it	U266/velR	CVCL_T031	Cell lines
Derived from it	U266B1-Fluc-EmGFP	CVCL_D5KP	Cell lines

1 to 10 of 14

See all 14 relatives

Cell banks12

Cell bank	Catalog number	Status	Source
ATCC	TIB-196		ATCC
BCRC	60437		BCRC
BCRJ	0240	Discontinued	Cellosaurus
CCTCC	GDC0301		Cellosaurus
CCTCC	GDC0325		Cellosaurus
CLS	300259		CLS
DSMZ	ACC-9		DSMZ
ECACC	85051003		ECACC
IBRC	C10148		Cellosaurus
IZSLER	BS TCL 233		Cellosaurus

1 to 10 of 12

See all 12 cell banks

Data dates

The date of each source this release read.

Cellosaurus: 2026-10-22; Cellosaurus
PubMed Central's articles: 2026-11-12; PubMed Central's articles
Our copy of PubMed: 2026-11-06; Our copy of PubMed

Sources 4

CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
PubMedNLM's terms

Each source's terms

CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
PubMedNLM's terms

Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.

For software

Read this cell line from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/cell-lines/v1/CVCL_0566

GET https://conductscience.org/api/cell-lines/v1/CVCL_0566/papers?page=2

API reference For AI assistants